IB 

Union Calendar No. 454 

116TH CONGRESS 

2D SESSION H. R. 1754 

[Report No. 116–554] 

To improve the integrity and safety of horseracing by requiring a uniform 

anti-doping and medication control program to be developed and enforced 

by an independent Horseracing Anti-Doping and Medication Control Authority. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 14, 2019 

Mr. TONKO (for himself, Mr. BARR, Ms. TITUS, Ms. SCHAKOWSKY, Mr. BLUMENAUER, Mr. CA ́RDENAS, Ms. CASTOR of Florida, Mr. KILMER, Mr. 

SEAN PATRICK MALONEY of New York, Mr. SUOZZI, Mr. SCHIFF, Mr. 

COHEN, Mr. MEEKS, Ms. DELAURO, Miss RICE of New York, Mr. COLLINS of New York, Ms. GABBARD, Mr. KRISHNAMOORTHI, Mr. RODNEY

DAVIS of Illinois, Mr. WATKINS, Mrs. WALORSKI, Mr. COOK, Mr. JOYCE

of Ohio, Mr. WOODALL, Mr. HOLLINGSWORTH, Mr. BUCHANAN, Mr. 

CARTER of Georgia, and Mr. KATKO) introduced the following bill; which 

was referred to the Committee on Energy and Commerce 


kjohnson on DSK79L0C42PROD with BILLS
2 

•HR 1754 RH

SEPTEMBER 29, 2020 

Additional sponsors: Ms. JUDY CHU of California, Ms. BROWNLEY of California, Mr. GRIJALVA, Mr. CICILLINE, Mr. ENGEL, Mr. HASTINGS, Mr. 

BRINDISI, Mr. BUDD, Mr. BRENDAN F. BOYLE of Pennsylvania, Mr. 

HECK, Mr. CRIST, Mr. LOWENTHAL, Mrs. CAROLYN B. MALONEY of New 

York, Mr. BYRNE, Mr. PRICE of North Carolina, Mr. ESPAILLAT, Mr. 

JOHNSON of Georgia, Mrs. NAPOLITANO, Ms. DEAN, Mrs. LOWEY, Mr. 

RUPPERSBERGER, Mrs. DEMINGS, Mr. POCAN, Ms. DELBENE, Mr. 

CARBAJAL, Mr. MALINOWSKI, Ms. VELA ́ZQUEZ, Ms. WASSERMAN

SCHULTZ, Mrs. RADEWAGEN, Mr. SOTO, Ms. MENG, Ms. KAPTUR, Mr. 

THOMPSON of California, Mr. DEFAZIO, Mr. HIMES, Mr. SCHNEIDER, 

Mr. UPTON, Mr. CALVERT, Mr. CLAY, Mr. BEYER, Mr. LANGEVIN, Ms. 

STEFANIK, Mr. CARTWRIGHT, Ms. WILD, Mr. HUNTER, Ms. BONAMICI, 

Ms. CLARKE of New York, Mr. HIGGINS of New York, Mr. JEFFRIES, 

Ms. CLARK of Massachusetts, Ms. MATSUI, Mr. CONNOLLY, Mr. 

SERRANO, Mr. KING of New York, Ms. ESHOO, Ms. SPEIER, Ms. LEE

of California, Mr. REED, Mr. TRONE, Mr. LIPINSKI, Mr. DEUTCH, Ms. 

NORTON, Mrs. BUSTOS, Ms. MUCARSEL-POWELL, Mr. PAYNE, Ms. SCANLON, Mr. KHANNA, Ms. HAALAND, Mrs. BROOKS of Indiana, Mr. HARDER of California, Mr. GAETZ, Mr. RASKIN, Ms. JAYAPAL, Mr. CUMMINGS, 

Mr. DOGGETT, Mr. SHERMAN, Mr. ESTES, Ms. SLOTKIN, Mr. ROUDA, 

Mr. GOMEZ, Mr. PANETTA, Mr. CORREA, Ms. UNDERWOOD, Mr. YOHO, 

Mr. ROUZER, Mr. QUIGLEY, Mr. LEVIN of Michigan, Mr. COX of California, Mr. ZELDIN, Mrs. DAVIS of California, Mr. CISNEROS, Mrs. 

AXNE, Mr. KIM, Mr. CROW, Mr. MCGOVERN, Mr. NEGUSE, Ms. ROYBALALLARD, Ms. TORRES SMALL of New Mexico, Mrs. MCBATH, Ms. 

FRANKEL, Mr. LAWSON of Florida, Ms. PORTER, Mr. CARSON of Indiana, Mr. LAMB, Mr. MORELLE, Mr. STAUBER, Mr. FITZPATRICK, Mr. 

BILIRAKIS, Mr. BERA, Mr. SWALWELL of California, Mr. SMITH of Washington, Mr. WALTZ, Ms. SA ́NCHEZ, Mr. MCNERNEY, Ms. CRAIG, Mr. 

HARRIS, Ms. BARRAGA ́N, Mr. MEUSER, Mr. BROWN of Maryland, Mr. 

DAVIDSON of Ohio, Mr. POSEY, Mrs. LAWRENCE, Mr. ROONEY of Florida, Mrs. WATSON COLEMAN, Ms. SHALALA, Mr. SCHWEIKERT, Mr. 

NEAL, Mr. DESAULNIER, Ms. HOULAHAN, Mr. PETERS, Mrs. FLETCHER, Mr. LARSEN of Washington, Ms. KUSTER of New Hampshire, Mr. 

MICHAEL F. DOYLE of Pennsylvania, Ms. ESCOBAR, Mr. NADLER, Mr. 

STEUBE, Mr. PAPPAS, Mrs. TORRES of California, Ms. SHERRILL, Mr. 

DELGADO, Mr. RUSH, Mr. SARBANES, Mr. GARCI ́A of Illinois, Mr. TIPTON, Mrs. HAYES, Ms. MCCOLLUM, Mr. LEWIS, Mr. COURTNEY, Ms. 

WEXTON, Mr. GREEN of Texas, Mrs. MURPHY of Florida, Mr. SMITH of 

New Jersey, Ms. STEVENS, Mr. BISHOP of Georgia, Mr. PASCRELL, Mr. 

SIRES, Mr. NORCROSS, Mr. STEIL, Mr. TAKANO, Mr. ALLRED, Mr. 

MCADAMS, Mr. LUJA ́N, Mr. LYNCH, Mrs. LURIA, Mr. KIND, Ms. BASS, 

Mr. LARSON of Connecticut, Mrs. BEATTY, Ms. SCHRIER, Mr. CASTEN

of Illinois, Ms. TLAIB, Mrs. MILLER, Ms. DEGETTE, Mr. FOSTER, Mr. 

LEVIN of California, Mr. MCEACHIN, Ms. JACKSON LEE, Mr. 

GOTTHEIMER, Ms. PINGREE, Mr. VARGAS, Ms. WILSON of Florida, Ms. 

PRESSLEY, Ms. ADAMS, Mr. RUIZ, Ms. FUDGE, Mr. ROSE of New York, 

Mr. KEATING, Mrs. DINGELL, Mr. HUFFMAN, Mr. HUDSON, Mr. 

SABLAN, Mr. CUNNINGHAM, Mr. AGUILAR, Ms. FINKENAUER, Mrs. 


kjohnson on DSK79L0C42PROD with BILLS
3 

•HR 1754 RH

TRAHAN, Mr. DAVID SCOTT of Georgia, Mr. KELLER, Mr. CURTIS, Mr. 

KENNEDY, Mr. KILDEE, Mr. GOODEN, Mr. CLEAVER, Mr. DANNY K. 

DAVIS of Illinois, Mr. LOEBSACK, Ms. MOORE, Mr. PERLMUTTER, Ms. 

WATERS, Mr. BUTTERFIELD, Mr. COOPER, Ms. DAVIDS of Kansas, Mr. 

BUCK, Mr. VEASEY, Mr. STANTON, Mr. RICHMOND, Mr. COMER, Mr. 

MCHENRY, Mr. GARAMENDI, Ms. GARCIA of Texas, Mr. GALLEGO, Ms. 

OMAR, Mr. CASE, Mr. PERRY, Mr. PETERSON, Mrs. LEE of Nevada, Mr. 

GRAVES of Georgia, Mr. MURPHY of North Carolina, Mr. GARCIA of California, Mr. CASTRO of Texas, Mr. ROGERS of Kentucky, Mr. YARMUTH, 

Mr. GUTHRIE, Mrs. KIRKPATRICK, and Ms. PLASKETT

SEPTEMBER 29, 2020 

Reported with an amendment; committed to the Committee of the Whole 

House on the State of the Union and ordered to be printed 

[Strike out all after the enacting clause and insert the part printed in italic] 

[For text of introduced bill, see copy of bill as introduced on March 14, 2019] 


kjohnson on DSK79L0C42PROD with BILLS
4 

•HR 1754 RH

A BILL 

To improve the integrity and safety of horseracing by requiring a uniform anti-doping and medication control program to be developed and enforced by an independent 

Horseracing Anti-Doping and Medication Control Authority. 


kjohnson on DSK79L0C42PROD with BILLS
5 

•HR 1754 RH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Horseracing Integrity 

5 and Safety Act of 2020’’. 

6 SEC. 2. DEFINITIONS. 

7 In this Act the following definitions apply: 

8 (1) AUTHORITY.—The term ‘‘Authority’’ means 

9 the Horseracing Integrity and Safety Authority des10 ignated by section 3(a). 

11 (2) COMMISSION.—The term ‘‘Commission’’ 

12 means the Federal Trade Commission. 

13 (3) COVERED HORSE.—The term ‘‘covered horse’’ 

14 means any Thoroughbred horse, or any other horse 

15 made subject to this Act by election of the applicable 

16 State racing commission or the breed governing orga17 nization for such horse under section 5(k), during the 

18 period— 

19 (A) beginning on the date of the horse’s first 

20 timed and reported workout at a racetrack that 

21 participates in covered horseraces or at a train22 ing facility; and 

23 (B) ending on the date on which the Au24 thority receives written notice that the horse has 

25 been retired. 


kjohnson on DSK79L0C42PROD with BILLS
6 

•HR 1754 RH

1 (4) COVERED HORSERACE.—The term ‘‘covered 

2 horserace’’ means any horserace involving covered 

3 horses that has a substantial relation to interstate 

4 commerce, including any Thoroughbred horserace that 

5 is the subject of interstate off-track or advance deposit 

6 wagers. 

7 (5) COVERED PERSONS.—The term ‘‘covered per8 sons’’ means all trainers, owners, breeders, jockeys, 

9 racetracks, veterinarians, persons (legal and natural) 

10 licensed by a State racing commission and the agents, 

11 assigns, and employees of such persons and other 

12 horse support personnel who are engaged in the care, 

13 training, or racing of covered horses. 

14 (6) EQUINE CONSTITUENCIES.—The term 

15 ‘‘equine constituencies’’ means, collectively, owners 

16 and breeders, trainers, racetracks, veterinarians, State 

17 racing commissions, and jockeys who are engaged in 

18 the care, training, or racing of covered horses. 

19 (7) EQUINE INDUSTRY REPRESENTATIVE.—The 

20 term ‘‘equine industry representative’’ means an or21 ganization regularly and significantly engaged in the 

22 equine industry, including organizations that rep23 resent the interests of, and whose membership consists 

24 of, owners and breeders, trainers, racetracks, veteri25 narians, State racing commissions, and jockeys. 


kjohnson on DSK79L0C42PROD with BILLS
7 

•HR 1754 RH

1 (8) HORSERACING ANTI-DOPING AND MEDICA2 TION CONTROL PROGRAM.—The term ‘‘horseracing 

3 anti-doping and medication control program’’ means 

4 the anti-doping and medication program established 

5 under section 6(a). 

6 (9) IMMEDIATE FAMILY MEMBER.—The term 

7 ‘‘immediate family member’’ shall include a spouse, 

8 domestic partner, mother, father, aunt, uncle, sibling, 

9 or child. 

10 (10) INTERSTATE OFF-TRACK WAGER.—The term 

11 ‘‘interstate off-track wager’’ has the meaning given 

12 such term in section 3 of the Interstate Horseracing 

13 Act of 1978 (15 U.S.C. 3002). 

14 (11) JOCKEY.—The term ‘‘jockey’’ means a rider 

15 or driver of a covered horse in covered horseraces. 

16 (12) OWNERS AND BREEDERS.—The term ‘‘own17 ers and breeders’’ means those persons who either hold 

18 ownership interests in covered horses or who are in 

19 the business of breeding covered horses. 

20 (13) PROGRAM EFFECTIVE DATE.—The term 

21 ‘‘program effective date’’ means the earlier of— 

22 (A) January 1 of the second year after the 

23 date of the enactment of this Act; or 

24 (B) the date that is 540 days after such 

25 date of enactment. 


kjohnson on DSK79L0C42PROD with BILLS
8 

•HR 1754 RH

1 (14) RACETRACK.—The term ‘‘racetrack’’ means 

2 an organization licensed by a State racing commis3 sion to conduct covered horseraces. 

4 (15) RACETRACK SAFETY PROGRAM.—The term 

5 ‘‘racetrack safety program’’ means the program estab6 lished under section 7(a). 

7 (16) STAKES RACE.—The term ‘‘stakes race’’ 

8 means any race so designated by the racetrack at 

9 which such race is run, including, without limitation, 

10 the races comprising the Breeders’ Cup World Cham11 pionships and the races designated as graded stakes 

12 by the American Graded Stakes Committee of the 

13 Thoroughbred Owners and Breeders Association. 

14 (17) STATE RACING COMMISSION.—The term 

15 ‘‘State racing commission’’ means an entity des16 ignated by State law or regulation that has jurisdic17 tion over the conduct of horseracing within the appli18 cable State. 

19 (18) TRAINER.—The term ‘‘trainer’’ means an 

20 individual engaged in the training of covered horses. 

21 (19) TRAINING FACILITY.—The term ‘‘training 

22 facility’’ means a location that is not a racetrack li23 censed by a State racing commission that operates 

24 primarily to house covered horses and conduct official 

25 timed workouts. 


kjohnson on DSK79L0C42PROD with BILLS
9 

•HR 1754 RH

1 (20) VETERINARIAN.—The term ‘‘veterinarian’’ 

2 means a licensed veterinarian who provides veteri3 nary services to covered horses. 

4 (21) WORKOUT.—The term ‘‘workout’’ means a 

5 timed running of a horse over a predetermined dis6 tance not associated with a race or its first qualifying 

7 race, if such race is made subject to this Act by elec8 tion under section 5(k) of the horse’s breed governing 

9 organization or the applicable State racing commis10 sion. 

11 SEC. 3. RECOGNITION OF THE HORSERACING INTEGRITY 

12 AND SAFETY AUTHORITY. 

13 (a) IN GENERAL.—The private, independent, self-regu14 latory, nonprofit corporation, to be known as the ‘‘Horse15 racing Integrity and Safety Authority’’, is recognized for 

16 purposes of developing and implementing a horseracing 

17 anti-doping and medication control program and a race18 track safety program for covered horses, covered persons, 

19 and covered horseraces. 

20 (b) BOARD OF DIRECTORS.— 

21 (1) MEMBERSHIP.—The Authority shall be gov22 erned by a board of directors (in this section referred 

23 to as the ‘‘Board’’) comprised of nine members as fol24 lows: 


kjohnson on DSK79L0C42PROD with BILLS
10 

•HR 1754 RH

1 (A) INDEPENDENT MEMBERS.—Five mem2 bers of the Board shall be independent members 

3 selected from outside the equine industry. 

4 (B) INDUSTRY MEMBERS.— 

5 (i) IN GENERAL.—Four members of the 

6 Board shall be industry members selected 

7 from among the various equine constitu8 encies. 

9 (ii) REPRESENTATION OF EQUINE CON10 STITUENCIES.—The industry members shall 

11 be representative of the various equine con12 stituencies, and shall include not more than 

13 one industry member from any one equine 

14 constituency. 

15 (2) CHAIR.—The chair of the Board shall be an 

16 independent member described in paragraph (1)(A). 

17 (3) BYLAWS.—The Board of the Authority shall 

18 be governed by bylaws for the operation of the Author19 ity with respect to— 

20 (A) the administrative structure and em21 ployees of the Authority; 

22 (B) the establishment of standing commit23 tees; 

24 (C) the procedures for filling vacancies on 

25 the Board and the standing committees; 


kjohnson on DSK79L0C42PROD with BILLS
11 

•HR 1754 RH

1 (D) term limits for members and termi2 nation of membership; and 

3 (E) any other matter the Board considers 

4 necessary. 

5 (c) STANDING COMMITTEES.— 

6 (1) ANTI-DOPING AND MEDICATION CONTROL

7 STANDING COMMITTEE.— 

8 (A) IN GENERAL.—The Authority shall es9 tablish an anti-doping and medication control 

10 standing committee, which shall provide advice 

11 and guidance to the Board on the development 

12 and maintenance of the horseracing anti-doping 

13 and medication control program. 

14 (B) MEMBERSHIP.—The anti-doping and 

15 medication control standing committee shall be 

16 comprised of seven members as follows: 

17 (i) INDEPENDENT MEMBERS.—A ma18 jority of the members shall be independent 

19 members selected from outside the equine in20 dustry. 

21 (ii) INDUSTRY MEMBERS.—A minority 

22 of the members shall be industry members 

23 selected to represent the various equine con24 stituencies, and shall include not more than 


kjohnson on DSK79L0C42PROD with BILLS
12 

•HR 1754 RH

1 one industry member from any one equine 

2 constituency. 

3 (iii) QUALIFICATION.—A majority of 

4 individuals selected to serve on the anti5 doping and medication control standing 

6 committee shall have significant, recent ex7 perience in anti-doping and medication 

8 control rules. 

9 (C) CHAIR.—The chair of the anti-doping 

10 and medication control standing committee shall 

11 be an independent member of the Board de12 scribed in subsection (b)(1)(A). 

13 (2) RACETRACK SAFETY STANDING COM14 MITTEE.— 

15 (A) IN GENERAL.—The Authority shall es16 tablish a racetrack safety standing committee, 

17 which shall provide advice and guidance to the 

18 Board on the development and maintenance of 

19 the racetrack safety program. 

20 (B) MEMBERSHIP.—The racetrack safety 

21 standing committee shall be comprised of seven 

22 members as follows: 

23 (i) INDEPENDENT MEMBERS.—A ma24 jority of the members shall be independent 


kjohnson on DSK79L0C42PROD with BILLS
13 

•HR 1754 RH

1 members selected from outside the equine in2 dustry. 

3 (ii) INDUSTRY MEMBERS.—A minority 

4 of the members shall be industry members 

5 selected to represent the various equine con6 stituencies. 

7 (C) CHAIR.—The chair of the racetrack 

8 safety standing committee shall be an industry 

9 member of the Board described in subsection 

10 (b)(1)(B). 

11 (d) NOMINATING COMMITTEE.— 

12 (1) MEMBERSHIP.— 

13 (A) IN GENERAL.—The nominating com14 mittee of the Authority shall be comprised of 

15 seven independent members selected from busi16 ness, sports, and academia. 

17 (B) INITIAL MEMBERSHIP.—The initial 

18 nominating committee members shall be set forth 

19 in the governing corporate documents of the Au20 thority. 

21 (C) VACANCIES.—After the initial com22 mittee members are appointed in accordance 

23 with subparagraph (B), vacancies shall be filled 

24 by the Board pursuant to rules established by the 

25 Authority. 


kjohnson on DSK79L0C42PROD with BILLS
14 

•HR 1754 RH

1 (2) CHAIR.—The chair of the nominating com2 mittee shall be selected by the nominating committee 

3 from among the members of the nominating com4 mittee. 

5 (3) SELECTION OF MEMBERS OF THE BOARD AND

6 STANDING COMMITTEES.— 

7 (A) INITIAL MEMBERS.—The nominating 

8 committee shall select the initial members of the 

9 Board and the standing committees described in 

10 subsection (c). 

11 (B) SUBSEQUENT MEMBERS.— The nomi12 nating committee shall recommend individuals 

13 to fill any vacancy on the Board or on such 

14 standing committees. 

15 (e) CONFLICTS OF INTEREST.—To avoid conflicts of 

16 interest, the following individuals may not be selected as 

17 a member of the Board or as an independent member of 

18 a nominating or standing committee under this section: 

19 (1) An individual who has a financial interest 

20 in, or provides goods or services to, covered horses. 

21 (2) An official or officer— 

22 (A) of an equine industry representative; or 

23 (B) who serves in a governance or policy24 making capacity for an equine industry rep25 resentative. 


kjohnson on DSK79L0C42PROD with BILLS
15 

•HR 1754 RH

1 (3) An employee of, or an individual who has a 

2 business or commercial relationship with, an indi3 vidual described in paragraph (1) or (2). 

4 (4) An immediate family member of an indi5 vidual described in paragraph (1) or (2). 

6 (f) FUNDING.— 

7 (1) INITIAL FUNDING.— 

8 (A) IN GENERAL.—Initial funding to estab9 lish the Authority and underwrite its operations 

10 before the program effective date shall be pro11 vided by loans obtained by the Authority. 

12 (B) BORROWING.—The Authority may bor13 row funds toward the funding of its operations. 

14 (C) ANNUAL CALCULATION OF AMOUNTS RE15 QUIRED.— 

16 (i) IN GENERAL.—Not later than the 

17 date that is 90 days before the program ef18 fective date, and not later than November 1 

19 each year thereafter, the Authority shall de20 termine and provide to each State racing 

21 commission the estimated amount required 

22 from the State— 

23 (I) to fund the State’s propor24 tionate share of the horseracing anti25 doping and medication control proVerDate Sep 11 2014 01:21 Sep 30, 2020 Jkt 099200 PO 00000 Frm 00015 Fmt 6652 Sfmt 6203 E:\BILLS\H1754.RH H1754

kjohnson on DSK79L0C42PROD with BILLS
16 

•HR 1754 RH

1 gram and the racetrack safety program 

2 for the next calendar year; and 

3 (II) to liquidate the State’s pro4 portionate share of any loan or fund5 ing shortfall in the current calendar 

6 year and any previous calendar year. 

7 (ii) BASIS OF CALCULATION.—The 

8 amounts calculated under clause (i) shall— 

9 (I) be based on— 

10 (aa) the annual budget of the 

11 Authority for the following cal12 endar year, as approved by the 

13 Board; and 

14 (bb) the projected amount of 

15 covered racing starts for the year 

16 in each State; and 

17 (II) take into account other 

18 sources of Authority revenue. 

19 (iii) REQUIREMENTS REGARDING

20 BUDGETS OF AUTHORITY.— 

21 (I) INITIAL BUDGET.—The initial 

22 budget of the Authority shall require 

the approval of 2 23 ⁄3 of the Board. 

24 (II) SUBSEQUENT BUDGETS.— 

25 Any subsequent budget that exceeds the 


kjohnson on DSK79L0C42PROD with BILLS
17 

•HR 1754 RH

1 budget of the preceding calendar year 

2 by more than 5 percent shall require 

the approval of 2 3 ⁄3 of the Board. 

4 (iv) RATE INCREASES.— 

5 (I) IN GENERAL.—A proposed in6 crease in the amount required under 

7 this subparagraph shall be reported to 

8 the Commission. 

9 (II) NOTICE AND COMMENT.—The 

10 Commission shall publish in the Fed11 eral Register such a proposed increase 

12 and provide an opportunity for public 

13 comment. 

14 (2) ASSESSMENT AND COLLECTION OF FEES BY

15 STATES.— 

16 (A) NOTICE OF ELECTION.—Any State rac17 ing commission that elects to remit fees pursuant 

18 to this subsection shall notify the Authority of 

19 such election not later than 60 days before the 

20 program effective date. 

21 (B) REQUIREMENT TO REMIT FEES.—After 

22 a State racing commission makes a notification 

23 under subparagraph (A), the election shall re24 main in effect and the State racing commission 

25 shall be required to remit fees pursuant to this 


kjohnson on DSK79L0C42PROD with BILLS
18 

•HR 1754 RH

1 subsection according to a schedule established in 

2 rule developed by the Authority and approved by 

3 the Commission. 

4 (C) WITHDRAWAL OF ELECTION.—A State 

5 racing commission may cease remitting fees 

6 under this subsection not earlier than one year 

7 after notifying the Authority of the intent of the 

8 State racing commission to do so. 

9 (D) DETERMINATION OF METHODS.—Each 

10 State racing commission shall determine, subject 

11 to the applicable laws, regulations, and contracts 

12 of the State, the method by which the requisite 

13 amount of fees, such as foal registration fees, 

14 sales contributions, starter fees, and track fees, 

15 and other fees on covered persons, shall be allo16 cated, assessed, and collected. 

17 (3) ASSESSMENT AND COLLECTION OF FEES BY

18 THE AUTHORITY.— 

19 (A) CALCULATION.—If a State racing com20 mission does not elect to remit fees pursuant to 

21 paragraph (2) or withdraws its election under 

22 such paragraph, the Authority shall, not less fre23 quently than monthly, calculate the applicable 

24 fee per racing start multiplied by the number of 


kjohnson on DSK79L0C42PROD with BILLS
19 

•HR 1754 RH

1 racing starts in the State during the preceding 

2 month. 

3 (B) ALLOCATION.—The Authority shall allo4 cate equitably the amount calculated under sub5 paragraph (A) collected among covered persons 

6 involved with covered horseraces pursuant to 

7 such rules as the Authority may promulgate. 

8 (C) ASSESSMENT AND COLLECTION.— 

9 (i) IN GENERAL.—The Authority shall 

10 assess a fee equal to the allocation made 

11 under subparagraph (B) and shall collect 

12 such fee according to such rules as the Au13 thority may promulgate. 

14 (ii) REMITTANCE OF FEES.—Covered 

15 persons described in subparagraph (B) shall 

16 be required to remit such fees to the Author17 ity. 

18 (D) LIMITATION.—A State racing commis19 sion that does not elect to remit fees pursuant to 

20 paragraph (2) or that withdraws its election 

21 under such paragraph shall not impose or collect 

22 from any person a fee or tax relating to anti23 doping and medication control or racetrack safe24 ty matters for covered horseraces. 


kjohnson on DSK79L0C42PROD with BILLS
20 

•HR 1754 RH

1 (4) FEES AND FINES.—Fees and fines imposed 

2 by the Authority shall be allocated toward funding of 

3 the Authority and its activities. 

4 (5) RULE OF CONSTRUCTION.—Nothing in this 

5 Act shall be construed to require— 

6 (A) the appropriation of any amount to the 

7 Authority; or 

8 (B) the Federal Government to guarantee 

9 the debts of the Authority. 

10 (g) QUORUM.—For all items where Board approval is 

11 required, the Authority shall have present a majority of 

12 independent members. 

13 SEC. 4. FEDERAL TRADE COMMISSION OVERSIGHT. 

14 (a) IN GENERAL.—The Authority shall submit to the 

15 Commission, in accordance with such rules as the Commis16 sion may prescribe under section 553 of title 5, United 

17 States Code, any proposed rule, or proposed modification 

18 to a rule, of the Authority relating to— 

19 (1) the bylaws of the Authority; 

20 (2) a list of permitted and prohibited medica21 tions, substances, and methods, including allowable 

22 limits of permitted medications, substances, and 

23 methods; 

24 (3) laboratory standards for accreditation and 

25 protocols; 


kjohnson on DSK79L0C42PROD with BILLS
21 

•HR 1754 RH

1 (4) standards for racing surface quality mainte2 nance; 

3 (5) racetrack safety standards and protocols; 

4 (6) a program for injury and fatality data anal5 ysis; 

6 (7) a program of research and education on safe7 ty, performance, and anti-doping and medication 

8 control; 

9 (8) a description of safety, performance, and 

10 anti-doping and medication control rule violations 

11 applicable to covered horses and covered persons; 

12 (9) a schedule of civil sanctions for violations; 

13 (10) a process or procedures for disciplinary 

14 hearings; and 

15 (11) a formula or methodology for determining 

16 assessments described in section 3(f). 

17 (b) PUBLICATION AND COMMENT.— 

18 (1) IN GENERAL.—The Commission shall— 

19 (A) publish in the Federal Register each 

20 proposed rule or modification submitted under 

21 subsection (a); and 

22 (B) provide an opportunity for public com23 ment. 

24 (2) APPROVAL REQUIRED.—A proposed rule, or 

25 a proposed modification to a rule, of the Authority 


kjohnson on DSK79L0C42PROD with BILLS
22 

•HR 1754 RH

1 shall not take effect unless the proposed rule or modi2 fication has been approved by the Commission. 

3 (c) DECISION ON PROPOSED RULE OR MODIFICATION

4 TO A RULE.— 

5 (1) IN GENERAL.—Not later than 60 days after 

6 the date on which a proposed rule or modification is 

7 published in the Federal Register, the Commission 

8 shall approve or disapprove the proposed rule or 

9 modification. 

10 (2) CONDITIONS.—The Commission shall ap11 prove a proposed rule or modification if the Commis12 sion finds that the proposed rule or modification is 

13 consistent with— 

14 (A) this Act; and 

15 (B) applicable rules approved by the Com16 mission. 

17 (3) REVISION OF PROPOSED RULE OR MODIFICA18 TION.— 

19 (A) IN GENERAL.—In the case of dis20 approval of a proposed rule or modification 

21 under this subsection, not later than 30 days 

22 after the issuance of the disapproval, the Com23 mission shall make recommendations to the Au24 thority to modify the proposed rule or modifica25 tion. 


kjohnson on DSK79L0C42PROD with BILLS
23 

•HR 1754 RH

1 (B) RESUBMISSION.—The Authority may 

2 resubmit for approval by the Commission a pro3 posed rule or modification that incorporates the 

4 modifications recommended under subparagraph 

5 (A). 

6 (d) PROPOSED STANDARDS AND PROCEDURES.— 

7 (1) IN GENERAL.—The Authority shall submit to 

8 the Commission any proposed rule, standard, or pro9 cedure developed by the Authority to carry out the 

10 horseracing anti-doping and medication control pro11 gram or the racetrack safety program. 

12 (2) NOTICE AND COMMENT.—The Commission 

13 shall publish in the Federal Register any such pro14 posed rule, standard, or procedure and provide an op15 portunity for public comment. 

16 (e) INTERIM FINAL RULES.—The Commission may 

17 adopt an interim final rule, to take effect immediately, 

18 under conditions specified in section 553(b)(B) of title 5, 

19 United States Code, if the Commission finds that such a 

20 rule is necessary to protect— 

21 (1) the health and safety of covered horses; or 

22 (2) the integrity of covered horseraces and wager23 ing on those horseraces. 


kjohnson on DSK79L0C42PROD with BILLS
24 

•HR 1754 RH

1 SEC. 5. JURISDICTION OF THE COMMISSION AND THE 

2 HORSERACING INTEGRITY AND SAFETY AU3 THORITY. 

4 (a) IN GENERAL.—Beginning on the program effective 

5 date, the Commission, the Authority, and the anti-doping 

6 and medication control enforcement agency, each within the 

7 scope of their powers and responsibilities under this Act, 

8 as limited by subsection (j), shall— 

9 (1) implement and enforce the horseracing anti10 doping and medication control program and the race11 track safety program; 

12 (2) exercise independent and exclusive national 

13 authority over— 

14 (A) the safety, welfare, and integrity of cov15 ered horses, covered persons, and covered 

16 horseraces; and 

17 (B) all horseracing safety, performance, and 

18 anti-doping and medication control matters for 

19 covered horses, covered persons, and covered 

20 horseraces; and 

21 (3) have safety, performance, and anti-doping 

22 and medication control authority over covered persons 

23 similar to such authority of the State racing commis24 sions before the program effective date. 

25 (b) PREEMPTION.—The rules of the Authority promul26 gated in accordance with this Act shall preempt any proviVerDate Sep 11 2014 01:21 Sep 30, 2020 Jkt 099200 PO 00000 Frm 00024 Fmt 6652 Sfmt 6203 E:\BILLS\H1754.RH H1754

kjohnson on DSK79L0C42PROD with BILLS
25 

•HR 1754 RH

1 sion of State law or regulation with respect to matters with2 in the jurisdiction of the Authority under this Act, as lim3 ited by subsection (j). Nothing contained in this Act shall 

4 be construed to limit the authority of the Commission under 

5 any other provision of law. 

6 (c) DUTIES.— 

7 (1) IN GENERAL.—The Authority— 

8 (A) shall develop uniform procedures and 

9 rules authorizing— 

10 (i) access to offices, racetrack facilities, 

11 other places of business, books, records, and 

12 personal property of covered persons that 

13 are used in the care, treatment, training, 

14 and racing of covered horses; 

15 (ii) issuance and enforcement of sub16 poenas and subpoenas duces tecum; and 

17 (iii) other investigatory powers of the 

18 nature and scope exercised by State racing 

19 commissions before the program effective 

20 date; and 

21 (B) with respect to an unfair or deceptive 

22 act or practice described in section 10, may rec23 ommend that the Commission commence an en24 forcement action. 


kjohnson on DSK79L0C42PROD with BILLS
26 

•HR 1754 RH

1 (2) APPROVAL OF COMMISSION.—The procedures 

2 and rules developed under paragraph (1)(A) shall be 

3 subject to approval by the Commission in accordance 

4 with section 4. 

5 (d) REGISTRATION OF COVERED PERSONS WITH AU6 THORITY.— 

7 (1) IN GENERAL.—As a condition of partici8 pating in covered races and in the care, ownership, 

9 treatment, and training of covered horses, a covered 

10 person shall register with the Authority in accordance 

11 with rules promulgated by the Authority and ap12 proved by the Commission in accordance with section 

13 4. 

14 (2) AGREEMENT WITH RESPECT TO AUTHORITY

15 RULES, STANDARDS, AND PROCEDURES.—Registration 

16 under this subsection shall include an agreement by 

17 the covered person to be subject to and comply with 

18 the rules, standards, and procedures developed and 

19 approved under subsection (c). 

20 (3) COOPERATION.—A covered person registered 

21 under this subsection shall, at all times— 

22 (A) cooperate with the Commission, the Au23 thority, the anti-doping and medication control 

24 enforcement agency, and any respective designee, 

25 during any civil investigation; and 


kjohnson on DSK79L0C42PROD with BILLS
27 

•HR 1754 RH

1 (B) respond truthfully and completely to the 

2 best of the knowledge of the covered person if 

3 questioned by the Commission, the Authority, the 

4 anti-doping and medication control enforcement 

5 agency, or any respective designee. 

6 (4) FAILURE TO COMPLY.—Any failure of a cov7 ered person to comply with this subsection shall be a 

8 violation of section 8(a)(2)(G). 

9 (e) ENFORCEMENT OF PROGRAMS.— 

10 (1) ANTI-DOPING AND MEDICATION CONTROL EN11 FORCEMENT AGENCY.— 

12 (A) AGREEMENT WITH USADA.—The Au13 thority shall seek to enter into an agreement 

14 with the United States Anti-Doping Agency 

15 under which the Agency acts as the anti-doping 

16 and medication control enforcement agency 

17 under this Act for services consistent with the 

18 horseracing anti-doping and medication control 

19 program. 

20 (B) AGREEMENT WITH OTHER ENTITY.—If 

21 the Authority and the United States Anti22 Doping Agency are unable to enter into the 

23 agreement described in subparagraph (A), the 

24 Authority shall enter into an agreement with an 

25 entity that is nationally recognized as being a 


kjohnson on DSK79L0C42PROD with BILLS
28 

•HR 1754 RH

1 medication regulation agency equal in qualifica2 tion to the United States Anti-Doping Agency to 

3 act as the anti-doping and medication control 

4 enforcement agency under this Act for services 

5 consistent with the horseracing anti-doping and 

6 medication control program. 

7 (C) NEGOTIATIONS.—Any negotiations 

8 under this paragraph shall be conducted in good 

9 faith and designed to achieve efficient, effective 

10 best practices for anti-doping and medication 

11 control and enforcement on commercially reason12 able terms. 

13 (D) ELEMENTS OF AGREEMENT.—Any 

14 agreement under this paragraph shall include a 

15 description of the scope of work, performance 

16 metrics, reporting obligations, and budgets of the 

17 United States Anti-Doping Agency while acting 

18 as the anti-doping and medication control en19 forcement agency under this Act, as well as a 

20 provision for the revision of the agreement to in21 crease in the scope of work as provided for in 

22 subsection (k), and any other matter the Author23 ity considers appropriate. 

24 (E) DUTIES AND POWERS OF ENFORCEMENT

25 AGENCY.—The anti-doping and medication conVerDate Sep 11 2014 01:21 Sep 30, 2020 Jkt 099200 PO 00000 Frm 00028 Fmt 6652 Sfmt 6203 E:\BILLS\H1754.RH H1754

kjohnson on DSK79L0C42PROD with BILLS
29 

•HR 1754 RH

1 trol enforcement agency under an agreement 

2 under this paragraph shall— 

3 (i) serve as the independent anti4 doping and medication control enforcement 

5 organization for covered horses, covered per6 sons, and covered horseraces, implementing 

7 the anti-doping and medication control pro8 gram on behalf of the Authority; 

9 (ii) ensure that covered horses and cov10 ered persons are deterred from using or ad11 ministering medications, substances, and 

12 methods in violation of the rules established 

13 in accordance with this Act; 

14 (iii) implement anti-doping education, 

15 research, testing, compliance and adjudica16 tion programs designed to prevent covered 

17 persons and covered horses from using or 

18 administering medications, substances, and 

19 methods in violation of the rules established 

20 in accordance with this Act; 

21 (iv) exercise the powers specified in 

22 section 6(c)(4) in accordance with that sec23 tion; and 


kjohnson on DSK79L0C42PROD with BILLS
30 

•HR 1754 RH

1 (v) implement and undertake any 

2 other responsibilities specified in the agree3 ment. 

4 (F) TERM AND EXTENSION.— 

5 (i) TERM OF INITIAL AGREEMENT.— 

6 The initial agreement entered into by the 

7 Authority under this paragraph shall be in 

8 effect for the 5-year period beginning on the 

9 program effective date. 

10 (ii) EXTENSION.—At the end of the 5- 

11 year period described in clause (i), the Au12 thority may— 

13 (I) extend the term of the initial 

14 agreement under this paragraph for 

15 such additional term as is provided by 

16 the rules of the Authority and con17 sistent with this Act; or 

18 (II) enter into an agreement meet19 ing the requirements of this paragraph 

20 with an entity described by subpara21 graph (B) for such term as is provided 

22 by such rules and consistent with this 

23 Act. 

24 (2) AGREEMENTS FOR ENFORCEMENT BY STATE

25 RACING COMMISSIONS.— 


kjohnson on DSK79L0C42PROD with BILLS
31 

•HR 1754 RH

1 (A) STATE RACING COMMISSIONS.— 

2 (i) RACETRACK SAFETY PROGRAM.— 

3 The Authority may enter into agreements 

4 with State racing commissions for services 

5 consistent with the enforcement of the race6 track safety program. 

7 (ii) ANTI-DOPING AND MEDICATION

8 CONTROL PROGRAM.—The anti-doping and 

9 medication control enforcement agency may 

10 enter into agreements with State racing 

11 commissions for services consistent with the 

12 enforcement of the anti-doping and medica13 tion control program. 

14 (B) ELEMENTS OF AGREEMENTS.—Any 

15 agreement under this paragraph shall include a 

16 description of the scope of work, performance 

17 metrics, reporting obligations, budgets, and any 

18 other matter the Authority considers appro19 priate. 

20 (3) ENFORCEMENT OF STANDARDS.—The Au21 thority may coordinate with State racing commis22 sions and other State regulatory agencies to monitor 

23 and enforce racetrack compliance with the standards 

24 developed under paragraphs (1) and (2) of section 

25 7(c). 


kjohnson on DSK79L0C42PROD with BILLS
32 

•HR 1754 RH

1 (f) PROCEDURES WITH RESPECT TO RULES OF AU2 THORITY.— 

3 (1) ANTI-DOPING AND MEDICATION CONTROL.— 

4 (A) IN GENERAL.—Recommendations for 

5 rules regarding anti-doping and medication con6 trol shall be developed in accordance with section 

7 6. 

8 (B) CONSULTATION.—The anti-doping and 

9 medication control enforcement agency shall con10 sult with the anti-doping and medication control 

11 standing committee and the Board of the Author12 ity on all anti-doping and medication control 

13 rules of the Authority. 

14 (2) RACETRACK SAFETY.—Recommendations for 

15 rules regarding racetrack safety shall be developed by 

16 the racetrack safety standing committee of the Author17 ity 

18 (g) SUBPOENA AND INVESTIGATORY AUTHORITY.—The 

19 Authority shall have subpoena and investigatory authority 

20 with respect to civil violations committed under its jurisdic21 tion. 

22 (h) CIVIL PENALTIES.—The Authority shall develop a 

23 list of civil penalties with respect to the enforcement of rules 

24 for covered persons and covered horseraces under its juris25 diction. 


kjohnson on DSK79L0C42PROD with BILLS
33 

•HR 1754 RH

1 (i) CIVIL ACTIONS.— 

2 (1) IN GENERAL.—In addition to civil sanctions 

3 imposed under section 8, the Authority may com4 mence a civil action against a covered person or race5 track that has engaged, is engaged, or is about to en6 gage, in acts or practices constituting a violation of 

7 this Act or any rule established under this Act in the 

8 proper district court of the United States, the United 

9 States District Court for the District of Columbia, or 

10 the United States courts of any territory or other 

11 place subject to the jurisdiction of the United States, 

12 to enjoin such acts or practices, to enforce any civil 

13 sanctions imposed under that section, and for all 

14 other relief to which the Authority may be entitled. 

15 (2) INJUNCTIONS AND RESTRAINING ORDERS.— 

16 With respect to a civil action commenced under para17 graph (1), upon a proper showing, a permanent or 

18 temporary injunction or restraining order shall be 

19 granted without bond. 

20 (j) LIMITATIONS ON AUTHORITY.— 

21 (1) PROSPECTIVE APPLICATION.—The jurisdic22 tion and authority of the Authority and the Commis23 sion with respect to the horseracing anti-doping and 

24 medication control program and the racetrack safety 

25 program shall be prospective only. 


kjohnson on DSK79L0C42PROD with BILLS
34 

•HR 1754 RH

1 (2) PREVIOUS MATTERS.— 

2 (A) IN GENERAL.—The Authority and the 

3 Commission may not investigate, prosecute, ad4 judicate, or penalize conduct in violation of the 

5 horseracing anti-doping and medication control 

6 program and the racetrack safety program that 

7 occurs before the program effective date. 

8 (B) STATE RACING COMMISSION.—With re9 spect to conduct described in subparagraph (A), 

10 the applicable State racing commission shall re11 tain authority until the final resolution of the 

12 matter. 

13 (3) OTHER LAWS UNAFFECTED.—This Act shall 

14 not be construed to modify, impair or restrict the op15 eration of the general laws or regulations, as may be 

16 amended from time to time, of the United States, the 

17 States and their political subdivisions relating to 

18 criminal conduct, cruelty to animals, matters unre19 lated to antidoping, medication control and racetrack 

20 and racing safety of covered horses and covered races, 

21 and the use of medication in human participants in 

22 covered races. 

23 (k) ELECTION FOR OTHER BREED COVERAGE UNDER

24 ACT.— 


kjohnson on DSK79L0C42PROD with BILLS
35 

•HR 1754 RH

1 (1) IN GENERAL.—A State racing commission or 

2 a breed governing organization for a breed of horses 

3 other than Thoroughbred horses may elect to have 

4 such breed be covered by this Act by the filing of a 

5 designated election form and subsequent approval by 

6 the Authority. A State racing commission may elect 

7 to have a breed covered by this Act for the applicable 

8 State only. 

9 (2) ELECTION CONDITIONAL ON FUNDING MECHA10 NISM.—A commission or organization may not make 

11 an election under paragraph (1) unless the commis12 sion or organization has in place a mechanism to 

13 provide sufficient funds to cover the costs of the ad14 ministration of this Act with respect to the horses that 

15 will be covered by this Act as a result of the election. 

16 (3) APPORTIONMENT.—The Authority shall ap17 portion costs described in paragraph (2) in connec18 tion with an election under paragraph (1) fairly 

19 among all impacted segments of the horseracing in20 dustry, subject to approval by the Commission in ac21 cordance with section 4. Such apportionment may not 

22 provide for the allocation of costs or funds among 

23 breeds of horses. 


kjohnson on DSK79L0C42PROD with BILLS
36 

•HR 1754 RH

1 SEC. 6. HORSERACING ANTI-DOPING AND MEDICATION 

2 CONTROL PROGRAM. 

3 (a) PROGRAM REQUIRED.— 

4 (1) IN GENERAL.—Not later than the program 

5 effective date, and after notice and an opportunity for 

6 public comment in accordance with section 4, the Au7 thority shall establish a horseracing anti-doping and 

8 medication control program applicable to all covered 

9 horses, covered persons, and covered horseraces in ac10 cordance with the registration of covered persons 

11 under section 5(d). 

12 (2) CONSIDERATION OF OTHER BREEDS.—In de13 veloping the horseracing anti-doping and medication 

14 control program with respect to a breed of horse that 

15 is made subject to this Act by election of a State rac16 ing commission or the breed governing organization 

17 for such horse under section 5(k), the Authority shall 

18 consider the unique characteristics of such breed. 

19 (b) CONSIDERATIONS IN DEVELOPMENT OF PRO20 GRAM.—In developing the horseracing anti-doping and 

21 medication control program, the Authority shall take into 

22 consideration the following: 

23 (1) Covered horses should compete only when 

24 they are free from the influence of medications, other 

25 foreign substances, and methods that affect their per26 formance. 


kjohnson on DSK79L0C42PROD with BILLS
37 

•HR 1754 RH

1 (2) Covered horses that are injured or unsound 

2 should not train or participate in covered races, and 

3 the use of medications, other foreign substances, and 

4 treatment methods that mask or deaden pain in order 

5 to allow injured or unsound horses to train or race 

6 should be prohibited. 

7 (3) Rules, standards, procedures, and protocols 

8 regulating medication and treatment methods for cov9 ered horses and covered races should be uniform and 

10 uniformly administered nationally. 

11 (4) To the extent consistent with this Act, consid12 eration should be given to international anti-doping 

13 and medication control standards of the International 

14 Federation of Horseracing Authorities and the Prin15 ciples of Veterinary Medical Ethics of the American 

16 Veterinary Medical Association. 

17 (5) The administration of medications and treat18 ment methods to covered horses should be based upon 

19 an examination and diagnosis that identifies an issue 

20 requiring treatment for which the medication or 

21 method represents an appropriate component of treat22 ment. 

23 (6) The amount of therapeutic medication that a 

24 covered horse receives should be the minimum necVerDate Sep 11 2014 01:21 Sep 30, 2020 Jkt 099200 PO 00000 Frm 00037 Fmt 6652 Sfmt 6203 E:\BILLS\H1754.RH H1754

kjohnson on DSK79L0C42PROD with BILLS
38 

•HR 1754 RH

1 essary to address the diagnosed health concerns iden2 tified during the examination and diagnostic process. 

3 (7) The welfare of covered horses, the integrity of 

4 the sport, and the confidence of the betting public re5 quire full disclosure to regulatory authorities regard6 ing the administration of medications and treatments 

7 to covered horses. 

8 (c) ACTIVITIES.—The following activities shall be car9 ried out under the horseracing anti-doping and medication 

10 control program: 

11 (1) STANDARDS FOR ANTI-DOPING AND MEDICA12 TION CONTROL.—Not later than 120 days before the 

13 program effective date, the Authority shall issue, by 

14 rule— 

15 (A) uniform standards for— 

16 (i) the administration of medication to 

17 covered horses by covered persons; and 

18 (ii) laboratory testing accreditation 

19 and protocols; and 

20 (B) a list of permitted and prohibited medi21 cations, substances, and methods, including al22 lowable limits of permitted medications, sub23 stances, and methods. 

24 (2) REVIEW PROCESS FOR ADMINISTRATION OF

25 MEDICATION.—The development of a review process 


kjohnson on DSK79L0C42PROD with BILLS
39 

•HR 1754 RH

1 for the administration of any medication to a covered 

2 horse during the 48-hour period preceding the next 

3 racing start of the covered horse. 

4 (3) AGREEMENT REQUIREMENTS.—The develop5 ment of requirements with respect to agreements 

6 under section 5(e). 

7 (4) ANTI-DOPING AND MEDICATION CONTROL EN8 FORCEMENT AGENCY.— 

9 (A) CONTROL RULES, PROTOCOLS, ETC.— 

10 Except as provided in paragraph (5), the anti11 doping and medication control program enforce12 ment agency under section 5(e) shall, in con13 sultation with the anti-doping and medication 

14 control standing committee of the Authority and 

15 consistent with international best practices, de16 velop and recommend anti-doping and medica17 tion control rules, protocols, policies, and guide18 lines for approval by the Authority. 

19 (B) RESULTS MANAGEMENT.—The anti20 doping and medication control enforcement 

21 agency shall conduct and oversee anti-doping 

22 and medication control results management, in23 cluding independent investigations, charging and 

24 adjudication of potential medication control rule 

25 violations, and the enforcement of any civil sancVerDate Sep 11 2014 01:21 Sep 30, 2020 Jkt 099200 PO 00000 Frm 00039 Fmt 6652 Sfmt 6203 E:\BILLS\H1754.RH H1754

kjohnson on DSK79L0C42PROD with BILLS
40 

•HR 1754 RH

1 tions for such violations. Any final decision or 

2 civil sanction of the anti-doping and medication 

3 control enforcement agency under this subpara4 graph shall be the final decision or civil sanction 

5 of the Authority, subject to review in accordance 

6 with section 9. 

7 (C) TESTING.—The anti-doping enforcement 

8 agency shall perform and manage test distribu9 tion planning (including intelligence-based test10 ing), the sample collection process, and in-com11 petition and out-of-competition testing (includ12 ing no-advance-notice testing). 

13 (D) TESTING LABORATORIES.—The anti14 doping and medication control enforcement 

15 agency shall accredit testing laboratories based 

16 upon the standards established under this Act, 

17 and shall monitor, test, and audit accredited lab18 oratories to ensure continuing compliance with 

19 accreditation standards. 

20 (5) ANTI-DOPING AND MEDICATION CONTROL

21 STANDING COMMITTEE.—The anti-doping and medi22 cation control standing committee shall, in consulta23 tion with the anti-doping and medication control en24 forcement agency, develop lists of permitted and pro25 hibited medications, methods, and substances for recVerDate Sep 11 2014 01:21 Sep 30, 2020 Jkt 099200 PO 00000 Frm 00040 Fmt 6652 Sfmt 6203 E:\BILLS\H1754.RH H1754

kjohnson on DSK79L0C42PROD with BILLS
41 

•HR 1754 RH

1 ommendation to, and approval by, the Authority. 

2 Any such list may prohibit the administration of any 

3 substance or method to a horse at any time after such 

4 horse becomes a covered horse if the Authority deter5 mines such substance or method has a long-term de6 grading effect on the soundness of a horse. 

7 (d) PROHIBITION.—Except as provided in subsections 

8 (e) and (f), the horseracing anti-doping and medication 

9 control program shall prohibit the administration of any 

10 prohibited or otherwise permitted substance to a covered 

11 horse within 48 hours of its next racing start, effective as 

12 of the program effective date. 

13 (e) ADVISORY COMMITTEE STUDY AND REPORT.— 

14 (1) IN GENERAL.—Not later than the program 

15 effective date, the Authority shall convene an advisory 

16 committee comprised of horseracing anti-doping and 

17 medication control industry experts, including a 

18 member designated by the anti-doping and medica19 tion control enforcement agency, to conduct a study 

20 on the use of furosemide on horses during the 48-hour 

21 period before the start of a race, including the effect 

22 of furosemide on equine health and the integrity of 

23 competition and any other matter the Authority con24 siders appropriate. 


kjohnson on DSK79L0C42PROD with BILLS
42 

•HR 1754 RH

1 (2) REPORT.—Not later than three years after 

2 the program effective date, the Authority shall direct 

3 the advisory committee convened under paragraph (1) 

4 to submit to the Authority a written report on the 

5 study conducted under that paragraph that includes 

6 recommended changes, if any, to the prohibition in 

7 subsection (d). 

8 (3) MODIFICATION OF PROHIBITION.— 

9 (A) IN GENERAL.—After receipt of the re10 port required by paragraph (2), the Authority 

11 may, by unanimous vote of the Board of the Au12 thority, modify the prohibition in subsection (d) 

13 and, notwithstanding subsection (f), any such 

14 modification shall apply to all States beginning 

15 on the date that is three years after the program 

16 effective date. 

17 (B) CONDITION.—In order for a unanimous 

18 vote described in subparagraph (A) to effect a 

19 modification of the prohibition in subsection (d), 

20 the vote must include unanimous adoption of 

21 each of the following findings: 

22 (i) That the modification is warranted. 

23 (ii) That the modification is in the best 

24 interests of horse racing. 


kjohnson on DSK79L0C42PROD with BILLS
43 

•HR 1754 RH

1 (iii) That furosemide has no perform2 ance enhancing effect on individual horses. 

3 (iv) That public confidence in the in4 tegrity and safety of racing would not be 

5 adversely affected by the modification. 

6 (f) EXEMPTION.— 

7 (1) IN GENERAL.—Except as provided in para8 graph (2), only during the three-year period begin9 ning on the program effective date, a State racing 

10 commission may submit to the Authority, at such 

11 time and in such manner as the Authority may re12 quire, a request for an exemption from the prohibition 

13 in subsection (d) with respect to the use of furosemide 

14 on covered horses during such period. 

15 (2) EXCEPTIONS.—An exemption under para16 graph (1) may not be requested for— 

17 (A) two-year-old covered horses; or 

18 (B) covered horses competing in stakes 

19 races. 

20 (3) CONTENTS OF REQUEST.—A request under 

21 paragraph (1) shall specify the applicable State rac22 ing commission’s requested limitations on the use of 

23 furosemide that would apply to the State under the 

24 horseracing anti-doping and medication control pro25 gram during such period. Such limitations shall be 


kjohnson on DSK79L0C42PROD with BILLS
44 

•HR 1754 RH

1 no less restrictive on the use and administration of 

2 furosemide than the restrictions set forth in State’s 

3 laws and regulations in effect as of September 1, 

4 2020. 

5 (4) GRANT OF EXEMPTION.—Subject to sub6 section (e)(3), the Authority shall grant an exemption 

7 requested under paragraph (1) for the remainder of 

8 such period and shall allow the use of furosemide on 

9 covered horses in the applicable State, in accordance 

10 with the requested limitations. 

11 (g) BASELINE ANTI-DOPING AND MEDICATION CON12 TROL RULES.— 

13 (1) IN GENERAL.—Subject to paragraph (3), the 

14 baseline anti-doping and medication control rules de15 scribed in paragraph (2) shall— 

16 (A) constitute the initial rules of the horse17 racing anti-doping and medication control pro18 gram; and 

19 (B) except as exempted pursuant to sub20 sections (e) and (f), remain in effect at all times 

21 after the program effective date. 

22 (2) BASELINE ANTI-DOPING MEDICATION CON23 TROL RULES DESCRIBED.— 


kjohnson on DSK79L0C42PROD with BILLS
45 

•HR 1754 RH

1 (A) IN GENERAL.—The baseline anti-doping 

2 and medication control rules described in this 

3 paragraph are the following: 

4 (i) The lists of permitted and prohib5 ited substances (including drugs, medica6 tions, and naturally occurring substances 

7 and synthetically occurring substances) in 

8 effect for the International Federation of 

9 Horseracing Authorities, including the 

10 International Federation of Horseracing 

11 Authorities International Screening Limits 

12 for urine, dated May 2019, and the Inter13 national Federation of Horseracing Au14 thorities International Screening Limits for 

15 plasma, dated May 2019. 

16 (ii) The World Anti-Doping Agency 

17 International Standard for Laboratories 

18 (version 10.0), dated November 12, 2019. 

19 (iii) The Association of Racing Com20 missioners International out-of-competition 

21 testing standards, Model Rules of Racing 

22 (version 9.2). 

23 (iv) The Association of Racing Com24 missioners International penalty and mulVerDate Sep 11 2014 01:21 Sep 30, 2020 Jkt 099200 PO 00000 Frm 00045 Fmt 6652 Sfmt 6203 E:\BILLS\H1754.RH H1754

kjohnson on DSK79L0C42PROD with BILLS
46 

•HR 1754 RH

1 tiple medication violation rules, Model 

2 Rules of Racing (version 6.2). 

3 (B) CONFLICT OF RULES.—In the case of a 

4 conflict among the rules described in subpara5 graph (A), the most stringent rule shall apply. 

6 (3) MODIFICATIONS TO BASELINE RULES.— 

7 (A) DEVELOPMENT BY ANTI-DOPING AND

8 MEDICATION CONTROL STANDING COMMITTEE.— 

9 The anti-doping and medication control stand10 ing committee, in consultation with the anti11 doping and medication control enforcement 

12 agency, may develop and submit to the Author13 ity for approval by the Authority proposed modi14 fications to the baseline anti-doping and medica15 tion control rules. 

16 (B) AUTHORITY APPROVAL.—If the Author17 ity approves a proposed modification under this 

18 paragraph, the proposed modification shall be 

19 submitted to and considered by the Commission 

20 in accordance with section 4. 

21 (C) ANTI-DOPING AND MEDICATION CON22 TROL ENFORCEMENT AGENCY VETO AUTHOR23 ITY.—The Authority shall not approve any pro24 posed modification that renders an anti-doping 

25 and medication control rule less stringent than 


kjohnson on DSK79L0C42PROD with BILLS
47 

•HR 1754 RH

1 the baseline anti-doping and medication control 

2 rules described in paragraph (2) (including by 

3 increasing permitted medication thresholds, add4 ing permitted medications, removing prohibited 

5 medications, or weakening enforcement mecha6 nisms) without the approval of the anti-doping 

7 and medication control enforcement agency. 

8 SEC. 7. RACETRACK SAFETY PROGRAM. 

9 (a) ESTABLISHMENT AND CONSIDERATIONS.— 

10 (1) IN GENERAL.—Not later than the program 

11 effective date, and after notice and an opportunity for 

12 public comment in accordance with section 4, the Au13 thority shall establish a racetrack safety program ap14 plicable to all covered horses, covered persons, and 

15 covered horseraces in accordance with the registration 

16 of covered persons under section 5(d). 

17 (2) CONSIDERATIONS IN DEVELOPMENT OF SAFE18 TY PROGRAM.—In the development of the horseracing 

19 safety program for covered horses, covered persons, 

20 and covered horseraces, the Authority and the Com21 mission shall take into consideration existing safety 

22 standards including the National Thoroughbred Rac23 ing Association Safety and Integrity Alliance Code of 

24 Standards, the International Federation of Horse25 racing Authority’s International Agreement on BreedVerDate Sep 11 2014 01:21 Sep 30, 2020 Jkt 099200 PO 00000 Frm 00047 Fmt 6652 Sfmt 6203 E:\BILLS\H1754.RH H1754

kjohnson on DSK79L0C42PROD with BILLS
48 

•HR 1754 RH

1 ing, Racing, and Wagering, and the British Horse2 racing Authority’s Equine Health and Welfare pro3 gram. 

4 (b) ELEMENTS OF HORSERACING SAFETY PRO5 GRAM.—The horseracing safety program shall include the 

6 following: 

7 (1) A set of training and racing safety standards 

8 and protocols taking into account regional differences 

9 and the character of differing racing facilities. 

10 (2) A uniform set of training and racing safety 

11 standards and protocols consistent with the humane 

12 treatment of covered horses, which may include lists 

13 of permitted and prohibited practices or methods 

14 (such as crop use). 

15 (3) A racing surface quality maintenance system 

16 that— 

17 (A) takes into account regional differences 

18 and the character of differing racing facilities; 

19 and 

20 (B) may include requirements for track sur21 face design and consistency and established 

22 standard operating procedures related to track 

23 surface, monitoring, and maintenance (such as 

24 standardized seasonal assessment, daily tracking, 

25 and measurement). 


kjohnson on DSK79L0C42PROD with BILLS
49 

•HR 1754 RH

1 (4) A uniform set of track safety standards and 

2 protocols, that may include rules governing oversight 

3 and movement of covered horses and human and 

4 equine injury reporting and prevention. 

5 (5) Programs for injury and fatality data anal6 ysis, that may include pre- and post-training and 

7 race inspections, use of a veterinarian’s list, and con8 cussion protocols. 

9 (6) The undertaking of investigations at race10 track and non-racetrack facilities related to safety 

11 violations. 

12 (7) Procedures for investigating, charging, and 

13 adjudicating violations and for the enforcement of 

14 civil sanctions for violations. 

15 (8) A schedule of civil sanctions for violations. 

16 (9) Disciplinary hearings, which may include 

17 binding arbitration, civil sanctions, and research. 

18 (10) Management of violation results. 

19 (11) Programs relating to safety and perform20 ance research and education. 

21 (12) An evaluation and accreditation program 

22 that ensures that racetracks in the United States meet 

23 the standards described in the elements of the Horse24 racing Safety Program. 


kjohnson on DSK79L0C42PROD with BILLS
50 

•HR 1754 RH

1 (c) ACTIVITIES.—The following activities shall be car2 ried out under the racetrack safety program: 

3 (1) STANDARDS FOR RACETRACK SAFETY.—The 

4 development, by the racetrack safety standing com5 mittee of the Authority in section 3(c)(2) of uniform 

6 standards for racetrack and horseracing safety. 

7 (2) STANDARDS FOR SAFETY AND PERFORMANCE

8 ACCREDITATION.— 

9 (A) IN GENERAL.—Not later than 120 days 

10 before the program effective date, the Authority, 

11 in consultation with the racetrack safety stand12 ing committee, shall issue, by rule in accordance 

13 with section 4— 

14 (i) safety and performance standards 

15 of accreditation for racetracks; and 

16 (ii) the process by which a racetrack 

17 may achieve and maintain accreditation by 

18 the Authority. 

19 (B) MODIFICATIONS.— 

20 (i) IN GENERAL.—The Authority may 

21 modify rules establishing the standards 

22 issued under subparagraph (A), as the Au23 thority considers appropriate. 

24 (ii) NOTICE AND COMMENT.—The 

25 Commission shall publish in the Federal 


kjohnson on DSK79L0C42PROD with BILLS
51 

•HR 1754 RH

1 Register any proposed rule of the Authority, 

2 and provide an opportunity for public com3 ment with respect to, any modification 

4 under clause (i) in accordance with section 

5 4. 

6 (C) EXTENSION OF PROVISIONAL OR IN7 TERIM ACCREDITATION.—The Authority may, by 

8 rule in accordance with section 4, extend provi9 sional or interim accreditation to a racetrack ac10 credited by the National Thoroughbred Racing 

11 Association Safety and Integrity Alliance on a 

12 date before the program effective date. 

13 (3) NATIONWIDE SAFETY AND PERFORMANCE

14 DATABASE.— 

15 (A) IN GENERAL.—Not later than one year 

16 after the program effective date, and after notice 

17 and an opportunity for public comment in ac18 cordance with section 4, the Authority, in con19 sultation with the Commission, shall develop and 

20 maintain a nationwide database of racehorse 

21 safety, performance, health, and injury informa22 tion for the purpose of conducting an epidemio23 logical study. 

24 (B) COLLECTION OF INFORMATION.—In ac25 cordance with the registration of covered persons 


kjohnson on DSK79L0C42PROD with BILLS
52 

•HR 1754 RH

1 under section 5(d), the Authority may require 

2 covered persons to collect and submit to the data3 base described in subparagraph (A) such infor4 mation as the Authority may require to further 

5 the goal of increased racehorse welfare. 

6 SEC. 8. RULE VIOLATIONS AND CIVIL SANCTIONS. 

7 (a) DESCRIPTION OF RULE VIOLATIONS.— 

8 (1) IN GENERAL.—The Authority shall issue, by 

9 rule in accordance with section 4, a description of 

10 safety, performance, and anti-doping and medication 

11 control rule violations applicable to covered horses 

12 and covered persons. 

13 (2) ELEMENTS.—The description of rule viola14 tions established under paragraph (1) may include 

15 the following: 

16 (A) With respect to a covered horse, strict li17 ability for covered trainers for— 

18 (i) the presence of a prohibited sub19 stance or method in a sample or the use of 

20 a prohibited substance or method; 

21 (ii) the presence of a permitted sub22 stance in a sample in excess of the amount 

23 allowed by the horseracing anti-doping and 

24 medication control program; and 


kjohnson on DSK79L0C42PROD with BILLS
53 

•HR 1754 RH

1 (iii) the use of a permitted method in 

2 violation of the applicable limitations estab3 lished under the horseracing anti-doping 

4 and medication control program. 

5 (B) Attempted use of a prohibited substance 

6 or method on a covered horse. 

7 (C) Possession of any prohibited substance 

8 or method. 

9 (D) Attempted possession of any prohibited 

10 substance or method. 

11 (E) Administration or attempted adminis12 tration of any prohibited substance or method on 

13 a covered horse. 

14 (F) Refusal or failure, without compelling 

15 justification, to submit a covered horse for sam16 ple collection. 

17 (G) Failure to cooperate with the Authority 

18 or an agent of the Authority during any inves19 tigation. 

20 (H) Failure to respond truthfully, to the 

21 best of a covered person’s knowledge, to a ques22 tion of the Authority or an agent of the Author23 ity with respect to any matter under the juris24 diction of the Authority. 


kjohnson on DSK79L0C42PROD with BILLS
54 

•HR 1754 RH

1 (I) Tampering or attempted tampering with 

2 the application of the safety, performance, or 

3 anti-doping and medication control rules or 

4 process adopted by the Authority, including— 

5 (i) the intentional interference, or an 

6 attempt to interfere, with an official or 

7 agent of the Authority; 

8 (ii) the procurement or the provision of 

9 fraudulent information to the Authority or 

10 agent; and 

11 (iii) the intimidation of, or an attempt 

12 to intimidate, a potential witness. 

13 (J) Trafficking or attempted trafficking in 

14 any prohibited substance or method. 

15 (K) Assisting, encouraging, aiding, abet16 ting, conspiring, covering up, or any other type 

17 of intentional complicity involving a safety, per18 formance, or anti-doping and medication control 

19 rule violation or the violation of a period of sus20 pension or eligibility. 

21 (L) Threatening or seeking to intimidate a 

22 person with the intent of discouraging the person 

23 from the good faith reporting to the Authority, 

24 an agent of the Authority or the Commission, or 

25 the anti-doping and medication control enforceVerDate Sep 11 2014 01:21 Sep 30, 2020 Jkt 099200 PO 00000 Frm 00054 Fmt 6652 Sfmt 6203 E:\BILLS\H1754.RH H1754

kjohnson on DSK79L0C42PROD with BILLS
55 

•HR 1754 RH

1 ment agency under section 5(e), of information 

2 that relates to— 

3 (i) an alleged safety, performance, or 

4 anti-doping and medication control rule 

5 violation; or 

6 (ii) alleged noncompliance with a safe7 ty, performance, or anti-doping and medi8 cation control rule. 

9 (b) TESTING LABORATORIES.— 

10 (1) ACCREDITATION AND STANDARDS.—Not later 

11 than 120 days before the program effective date, the 

12 Authority shall, in consultation with the anti-doping 

13 and medication control enforcement agency, establish, 

14 by rule in accordance with section 4— 

15 (A) standards of accreditation for labora16 tories involved in testing samples from covered 

17 horses; 

18 (B) the process for achieving and maintain19 ing accreditation; and 

20 (C) the standards and protocols for testing 

21 such samples. 

22 (2) ADMINISTRATION.—The accreditation of lab23 oratories and the conduct of audits of accredited lab24 oratories to ensure compliance with Authority rules 

25 shall be administered by the anti-doping and medicaVerDate Sep 11 2014 01:21 Sep 30, 2020 Jkt 099200 PO 00000 Frm 00055 Fmt 6652 Sfmt 6203 E:\BILLS\H1754.RH H1754

kjohnson on DSK79L0C42PROD with BILLS
56 

•HR 1754 RH

1 tion control enforcement agency. The anti-doping and 

2 medication control enforcement agency shall have the 

3 authority to require specific test samples to be di4 rected to and tested by laboratories having special ex5 pertise in the required tests. 

6 (3) EXTENSION OF PROVISIONAL OR INTERIM AC7 CREDITATION.—The Authority may, by rule in ac8 cordance with section 4, extend provisional or interim 

9 accreditation to a laboratory accredited by the Racing 

10 Medication and Testing Consortium, Inc., on a date 

11 before the program effective date. 

12 (4) SELECTION OF LABORATORIES.— 

13 (A) IN GENERAL.—Except as provided in 

14 paragraph (2), a State racing commission may 

15 select a laboratory accredited in accordance with 

16 the standards established under paragraph (1) to 

17 test samples taken in the applicable State. 

18 (B) SELECTION BY THE AUTHORITY.—If a 

19 State racing commission does not select an ac20 credited laboratory under subparagraph (A), the 

21 Authority shall select such a laboratory to test 

22 samples taken in the State concerned. 

23 (c) RESULTS MANAGEMENT AND DISCIPLINARY PROC24 ESS.— 


kjohnson on DSK79L0C42PROD with BILLS
57 

•HR 1754 RH

1 (1) IN GENERAL.—Not later than 120 days be2 fore the program effective date, the Authority shall es3 tablish in accordance with section 4— 

4 (A) rules for safety, performance, and anti5 doping and medication control results manage6 ment; and 

7 (B) the disciplinary process for safety, per8 formance, and anti-doping and medication con9 trol rule violations. 

10 (2) ELEMENTS.—The rules and process estab11 lished under paragraph (1) shall include the fol12 lowing: 

13 (A) Provisions for notification of safety, 

14 performance, and anti-doping and medication 

15 control rule violations. 

16 (B) Hearing procedures. 

17 (C) Standards for burden of proof. 

18 (D) Presumptions. 

19 (E) Evidentiary rules. 

20 (F) Appeals. 

21 (G) Guidelines for confidentiality and pub22 lic reporting of decisions. 

23 (3) DUE PROCESS.—The rules established under 

24 paragraph (1) shall provide for adequate due process, 

25 including impartial hearing officers or tribunals comVerDate Sep 11 2014 01:21 Sep 30, 2020 Jkt 099200 PO 00000 Frm 00057 Fmt 6652 Sfmt 6203 E:\BILLS\H1754.RH H1754

kjohnson on DSK79L0C42PROD with BILLS
58 

•HR 1754 RH

1 mensurate with the seriousness of the alleged safety, 

2 performance, or anti-doping and medication control 

3 rule violation and the possible civil sanctions for such 

4 violation. 

5 (d) CIVIL SANCTIONS.— 

6 (1) IN GENERAL.—The Authority shall establish 

7 uniform rules, in accordance with section 4, imposing 

8 civil sanctions against covered persons or covered 

9 horses for safety, performance, and anti-doping and 

10 medication control rule violations. 

11 (2) REQUIREMENTS.—The rules established 

12 under paragraph (1) shall— 

13 (A) take into account the unique aspects of 

14 horseracing; 

15 (B) be designed to ensure fair and trans16 parent horseraces; and 

17 (C) deter safety, performance, and anti18 doping and medication control rule violations. 

19 (3) SEVERITY.—The civil sanctions under para20 graph (1) may include— 

21 (A) lifetime bans from horseracing, 

22 disgorgement of purses, monetary fines and pen23 alties, and changes to the order of finish in cov24 ered races; and 


kjohnson on DSK79L0C42PROD with BILLS
59 

•HR 1754 RH

1 (B) with respect to anti-doping and medica2 tion control rule violators, an opportunity to re3 duce the applicable civil sanctions that is com4 parable to the opportunity provided by the Pro5 tocol for Olympic Movement Testing of the 

6 United States Anti-Doping Agency. 

7 (e) MODIFICATIONS.—The Authority may propose a 

8 modification to any rule established under this section as 

9 the Authority considers appropriate, and the proposed 

10 modification shall be submitted to and considered by the 

11 Commission in accordance with section 4. 

12 SEC. 9. REVIEW OF FINAL DECISIONS OF THE AUTHORITY. 

13 (a) NOTICE OF CIVIL SANCTIONS.— If the Authority 

14 imposes a final civil sanction for a violation committed by 

15 a covered person pursuant to the rules or standards of the 

16 Authority, the Authority shall promptly submit to the Com17 mission notice of the civil sanction in such form as the 

18 Commission may require. 

19 (b) REVIEW BY ADMINISTRATIVE LAW JUDGE.— 

20 (1) IN GENERAL.—With respect to a final civil 

21 sanction imposed by the Authority, on application by 

22 the Commission or a person aggrieved by the civil 

23 sanction filed not later than 30 days after the date 

24 on which notice under subsection (a) is submitted, the 


kjohnson on DSK79L0C42PROD with BILLS
60 

•HR 1754 RH

1 civil sanction shall be subject to de novo review by an 

2 administrative law judge. 

3 (2) NATURE OF REVIEW.— 

4 (A) IN GENERAL.—In matters reviewed 

5 under this subsection, the administrative law 

6 judge shall determine whether— 

7 (i) a person has engaged in such acts 

8 or practices, or has omitted such acts or 

9 practices, as the Authority has found the 

10 person to have engaged in or omitted; 

11 (ii) such acts, practices, or omissions 

12 are in violation of this Act or the anti13 doping and medication control or racetrack 

14 safety rules approved by the Commission; or 

15 (iii) the final civil sanction of the Au16 thority was arbitrary, capricious, an abuse 

17 of discretion, or otherwise not in accordance 

18 with law. 

19 (B) CONDUCT OF HEARING.—An adminis20 trative law judge shall conduct a hearing under 

21 this subsection in such a manner as the Commis22 sion may specify by rule, which shall conform to 

23 section 556 of title 5, United States Code. 

24 (3) DECISION BY ADMINISTRATIVE LAW

25 JUDGE.— 


kjohnson on DSK79L0C42PROD with BILLS
61 

•HR 1754 RH

1 (A) IN GENERAL.—With respect to a matter 

2 reviewed under this subsection, an administra3 tive law judge— 

4 (i) shall render a decision not later 

5 than 60 days after the conclusion of the 

6 hearing; 

7 (ii) may affirm, reverse, modify, set 

8 aside, or remand for further proceedings, in 

9 whole or in part, the final civil sanction of 

10 the Authority; and 

11 (iii) may make any finding or conclu12 sion that, in the judgment of the adminis13 trative law judge, is proper and based on 

14 the record. 

15 (B) FINAL DECISION.—A decision under 

16 this paragraph shall constitute the decision of 

17 the Commission without further proceedings un18 less a notice or an application for review is 

19 timely filed under subsection (c). 

20 (c) REVIEW BY COMMISSION.— 

21 (1) NOTICE OF REVIEW BY COMMISSION.—The 

22 Commission may, on its own motion, review any de23 cision of an administrative law judge issued under 

24 subsection (b)(3) by providing written notice to the 

25 Authority and any interested party not later than 30 


kjohnson on DSK79L0C42PROD with BILLS
62 

•HR 1754 RH

1 days after the date on which the administrative law 

2 judge issues the decision. 

3 (2) APPLICATION FOR REVIEW.— 

4 (A) IN GENERAL.—The Authority or a per5 son aggrieved by a decision issued under sub6 section (b)(3) may petition the Commission for 

7 review of such decision by filing an application 

8 for review not later than 30 days after the date 

9 on which the administrative law judge issues the 

10 decision. 

11 (B) EFFECT OF DENIAL OF APPLICATION

12 FOR REVIEW.—If an application for review 

13 under subparagraph (A) is denied, the decision 

14 of the administrative law judge shall constitute 

15 the decision of the Commission without further 

16 proceedings. 

17 (C) DISCRETION OF COMMISSION.— 

18 (i) IN GENERAL.—A decision with re19 spect to whether to grant an application for 

20 review under subparagraph (A) is subject to 

21 the discretion of the Commission. 

22 (ii) MATTERS TO BE CONSIDERED.—In 

23 determining whether to grant such an ap24 plication for review, the Commission shall 


kjohnson on DSK79L0C42PROD with BILLS
63 

•HR 1754 RH

1 consider whether the application makes a 

2 reasonable showing that— 

3 (I) a prejudicial error was com4 mitted in the conduct of the pro5 ceeding; or 

6 (II) the decision involved— 

7 (aa) an erroneous applica8 tion of the anti-doping and medi9 cation control or racetrack safety 

10 rules approved by the Commis11 sion; or 

12 (bb) an exercise of discretion 

13 or a decision of law or policy that 

14 warrants review by the Commis15 sion. 

16 (3) NATURE OF REVIEW.— 

17 (A) IN GENERAL.—In matters reviewed 

18 under this subsection, the Commission may— 

19 (i) affirm, reverse, modify, set aside, or 

20 remand for further proceedings, in whole or 

21 in part, the decision of the administrative 

22 law judge; and 

23 (ii) make any finding or conclusion 

24 that, in the judgement of the Commission, is 

25 proper and based on the record. 


kjohnson on DSK79L0C42PROD with BILLS
64 

•HR 1754 RH

1 (B) DE NOVO REVIEW.—The Commission 

2 shall review de novo the factual findings and 

3 conclusions of law made by the administrative 

4 law judge. 

5 (C) CONSIDERATION OF ADDITIONAL EVI6 DENCE.— 

7 (i) MOTION BY COMMISSION.—The 

8 Commission may, on its own motion, allow 

9 the consideration of additional evidence. 

10 (ii) MOTION BY A PARTY.— 

11 (I) IN GENERAL.—A party may 

12 file a motion to consider additional 

13 evidence at any time before the 

14 issuance of a decision by the Commis15 sion, which shall show, with particu16 larity, that— 

17 (aa) such additional evidence 

18 is material; and 

19 (bb) there were reasonable 

20 grounds for failure to submit the 

21 evidence previously. 

22 (II) PROCEDURE.—The Commis23 sion may— 

24 (aa) accept or hear addi25 tional evidence; or 


kjohnson on DSK79L0C42PROD with BILLS
65 

•HR 1754 RH

1 (bb) remand the proceeding 

2 to the administrative law judge 

3 for the consideration of additional 

4 evidence. 

5 (d) STAY OF PROCEEDINGS.—Review by an adminis6 trative law judge or the Commission under this section shall 

7 not operate as a stay of a final civil sanction of the Author8 ity unless the administrative law judge or Commission or9 ders such a stay. 

10 SEC. 10. UNFAIR OR DECEPTIVE ACTS OR PRACTICES. 

11 The sale of a covered horse, or of any other horse in 

12 anticipation of its future participation in a covered race, 

13 shall be considered an unfair or deceptive act or practice 

14 in or affecting commerce under section 5(a) of the Federal 

15 Trade Commission Act (15 U.S.C. 45(a)) if the seller— 

16 (1) knows or has reason to know the horse has 

17 been administered— 

18 (A) a bisphosphonate prior to the horse’s 

19 fourth birthday; or 

20 (B) any other substance or method the Au21 thority determines has a long-term degrading ef22 fect on the soundness of the covered horse; and 

23 (2) fails to disclose to the buyer the administra24 tion of the bisphosphonate or other substance or meth25 od described in paragraph (1)(B). 


kjohnson on DSK79L0C42PROD with BILLS
66 

•HR 1754 RH

1 SEC. 11. STATE DELEGATION; COOPERATION. 

2 (a) STATE DELEGATION.— 

3 (1) IN GENERAL.—The Authority may enter into 

4 an agreement with a State racing commission to im5 plement, within the jurisdiction of the State racing 

6 commission, a component of the racetrack safety pro7 gram or, with the concurrence of the anti-doping and 

8 medication control enforcement agency under section 

9 5(e), a component of the horseracing anti-doping and 

10 medication control program, if the Authority deter11 mines that the State racing commission has the abil12 ity to implement such component in accordance with 

13 the rules, standards, and requirements established by 

14 the Authority. 

15 (2) IMPLEMENTATION BY STATE RACING COMMIS16 SION.—A State racing commission or other appro17 priate regulatory body of a State may not implement 

18 such a component in a manner less restrictive than 

19 the rule, standard, or requirement established by the 

20 Authority. 

21 (b) COOPERATION.—To avoid duplication of functions, 

22 facilities, and personnel, and to attain closer coordination 

23 and greater effectiveness and economy in administration of 

24 Federal and State law, where conduct by any person subject 

25 to the horseracing medication control program or the race26 track safety program may involve both a medication control 


kjohnson on DSK79L0C42PROD with BILLS
67 

•HR 1754 RH

1 or racetrack safety rule violation and violation of Federal 

2 or State law, the Authority and Federal or State law en3 forcement authorities shall cooperate and share informa4 tion. 


kjohnson on DSK79L0C42PROD with BILLS
Union Calendar No. 454 

116TH CONGRESS 

2D SESSION H. R. 1754 

[Report No. 116–554] 

A BILL 

To improve the integrity and safety of horseracing 

Doping and Medication Control Authority. forced by an independent Horseracing Antition control program to be developed and enby requiring a uniform anti-doping and medicaSEPTEMBER 29, 2020 

Reported with an amendment; committed to the Comand ordered to be printed mittee of the Whole House on the State of the Union 


kjohnson on DSK79L0C42PROD with BILLS